Hôpital Roger Salengro, CHRU
Lille, France
NCT Number: NCT03380676
To better define the clinical characteristics of oromandibular dystonia, we aimed to study voice, speech and swallowing disorders in idiopathic oromandibular We planned to include consecutive patients followed in Lille Movement disorders department for idiopathic oromandibular dystonia and matched, healthy control subjects. Voice and speech disorders had to be assessed with the phonetic analysis, perceptive analysis and motor examination modules of the "Batterie d'Evaluation Clinique de la Dysarthrie" (Clinical Evaluation of Dysarthria), the Grade, Rough, Breathy, Asthenic, Strained scale, and a computer recording. Activities of daily living had to be assessed with the Oromandibular Dystonia Questionnaire, the Voice Handicap Index and the Deglutition Handicap Index.
Looking for future studies?
Notify Me8 year and older
All sexes
Observational
Lille, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 minutes at baseline
To describe the clinical characteristics of dysarthria in idiopathic oromandibular dystonia. Composite score (min=best=0; max=worst=151) including three subscales: phonetic production (min=worst=0; max=best=33); simple words (min=worst=0; max=best=88); complex words (min=wost=0; max=best=30).
Time frame: 1 minute at baseline
To describe the clinical characteristics of voice impairment in idiopathic oromandibular dystonia. Maximum phonation time was measured in seconds.
Time frame: 1 minute at baseline
To describe the clinical characteristics of voice impairment in idiopathic oromandibular dystonia. Frequency variations were measured in Hz.
Time frame: 1 minute at baseline
To describe the clinical characteristics of voice impairment in idiopathic oromandibular dystonia. The number of pauses was counted.
Time frame: 1 minute at baseline
To describe the clinical characteristics of voice impairment in idiopathic oromandibular dystonia. Total lecture time was measured in seconds.
Time frame: 1 minute at baseline
To describe the clinical characteristics of voice impairment in idiopathic oromandibular dystonia. Pauses duration was measured in seconds.
Time frame: 1 minute at baseline
To describe the clinical characteristics of voice impairment in idiopathic oromandibular dystonia. Fundamental frequency was measured in Hz
Time frame: 2 minutes at baseline
To describe the clinical characteristics of voice impairment in idiopathic oromandibular dystonia. Repetitions were measured in seconds.
Time frame: 1 minute at baseline
To describe the clinical characteristics of voice impairment in idiopathic oromandibular dystonia. Mean vocal intensity was measured in dB
Time frame: 10 minutes at baseline
To describe impairment of daily living activities in idiopathic oromandibular (min=best=0; max=worst=120)
Time frame: 5 minutes at baseline
To describe the clinical characteristics of swallowing difficulties in idiopathic oromandibular dystonia. Min=best=0; max=worst=4
Time frame: 10 minutes at baseline
To describe impairment of daily living activities in idiopathic oromandibular dystonia. Qualitative: 30 questions (possible answers: never; almost never; sometimes; often; always)
Time frame: 10 minutes at baseline
To describe impairment of daily living activities in idiopathic oromandibular dystonia. Qualitative: 25 questions (possible answers: never; almost never; sometimes; often; always)
Time frame: 5 minutes at baseline
To describe dysphonia: from 0 (normal) to 3 (severe)
Time frame: 5 minutes at baseline
Phonetic characteristics of voice: nine items, each quoted from A (normal) to E (strongly abnormal).
Time frame: 5 minutes at baseline
To describe the clinical characteristics of dysarthria in idiopathic oromandibular dystonia. Perceptive score (min=best=0; max=worst=20)
University Hospital, Lille
Other
Acronym: DOM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03351218
Central Nervous System Diseases, Dystonia, Primary
Paris, Île-de-France Region, France
View Trial DetailsNCT04173260
Central Nervous System Diseases, Dystonia, Primary
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03381456
Central Nervous System Diseases, Dystonia, Primary
Lille, France
View Trial DetailsNCT07309133
Central Nervous System Diseases, Dyskinesias
Newcastle upon Tyne, Tyne & Wear, United Kingdom
View Trial Details